Hepatic stellate cell single cell atlas reveals a highly similar activation process across liver disease aetiologies

Background & Aims: The progression of chronic liver disease (CLD) is characterized by excessive extracellular matrix deposition, disrupting hepatic architecture and function. Upon liver injury, hepatic stellate cells (HSCs) differentiate towards myofibroblasts and become inflammatory, prolif...

Full description

Saved in:
Bibliographic Details
Main Authors: Vincent Merens, Elisabeth Knetemann, Elif Gürbüz, Vincent De Smet, Nouredin Messaoudi, Hendrik Reynaert, Stefaan Verhulst, Leo A. van Grunsven
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:JHEP Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589555924002271
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846091652130668544
author Vincent Merens
Elisabeth Knetemann
Elif Gürbüz
Vincent De Smet
Nouredin Messaoudi
Hendrik Reynaert
Stefaan Verhulst
Leo A. van Grunsven
author_facet Vincent Merens
Elisabeth Knetemann
Elif Gürbüz
Vincent De Smet
Nouredin Messaoudi
Hendrik Reynaert
Stefaan Verhulst
Leo A. van Grunsven
author_sort Vincent Merens
collection DOAJ
description Background &amp; Aims: The progression of chronic liver disease (CLD) is characterized by excessive extracellular matrix deposition, disrupting hepatic architecture and function. Upon liver injury, hepatic stellate cells (HSCs) differentiate towards myofibroblasts and become inflammatory, proliferative and fibrogenic. To date, it is still unclear whether HSC activation is driven by similar mechanisms in different aetiologies. Methods: HSCs from multiple publicly available single-cell RNA-sequencing datasets were annotated and merged into a single-cell HSC activation atlas. Spheroid co-cultures of primary mouse hepatocytes/HSCs (n = 5) and ELISAs on patient plasma samples (n = 80) were performed to validate the mechanistic insight obtained from the HSC atlas. Results: We established an HSC activation atlas in which HSCs are clearly divided into three distinct transcriptomic profiles: quiescent HSCs, initiatory HSCs and myofibroblasts. These transcriptomic profiles are present in each of the investigated mouse liver injury models as well as in human CLDs, indicating that HSC activation is a conserved process. This activation process is driven by a core set of transcription factors independent of liver injury or species. Furthermore, we reveal novel ligands associated with activation of HSCs in multiple liver injury models and validate the profibrotic effect of parathyroid hormone. Finally, we identify COLEC10 as a conserved marker for quiescent HSCs and a biomarker of liver fibrosis in patients with different CLDs (p <0.0001). Conclusions: We reveal unexpected similarities in the regulatory mechanisms of HSCs across diverse liver injury settings and species. The HSC activation atlas has the potential to provide novel insights into liver fibrosis and steer novel treatment options. Impact and implications:: This study establishes a single-cell atlas of hepatic stellate cells across various liver injuries, highlighting a conserved activation process between different injuries and across species. The discovery of novel activating ligands and the biomarker COLEC10 in human plasma could be used to enhance diagnostic and therapeutic strategies. Additionally, the conserved activation process supports the use of any mouse model for mechanistic studies and testing of new anti-fibrotic compounds, streamlining preclinical research efforts.
format Article
id doaj-art-5e811f0d21c84c269030fde61dbc2c68
institution Kabale University
issn 2589-5559
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series JHEP Reports
spelling doaj-art-5e811f0d21c84c269030fde61dbc2c682025-01-10T04:38:03ZengElsevierJHEP Reports2589-55592025-01-0171101223Hepatic stellate cell single cell atlas reveals a highly similar activation process across liver disease aetiologiesVincent Merens0Elisabeth Knetemann1Elif Gürbüz2Vincent De Smet3Nouredin Messaoudi4Hendrik Reynaert5Stefaan Verhulst6Leo A. van Grunsven7Vrije Universiteit Brussel, Liver Cell Biology research group, Laarbeeklaan 103, 1090 Brussel, BelgiumVrije Universiteit Brussel, Liver Cell Biology research group, Laarbeeklaan 103, 1090 Brussel, BelgiumVrije Universiteit Brussel, Liver Cell Biology research group, Laarbeeklaan 103, 1090 Brussel, BelgiumVrije Universiteit Brussel, Liver Cell Biology research group, Laarbeeklaan 103, 1090 Brussel, Belgium; Department of Gastro-Enterology and Hepatology, Universitair Ziekenhuis Brussel, Brussels, BelgiumDepartment of Gastro-Enterology and Hepatology, Universitair Ziekenhuis Brussel, Brussels, BelgiumVrije Universiteit Brussel, Liver Cell Biology research group, Laarbeeklaan 103, 1090 Brussel, Belgium; Department of Gastro-Enterology and Hepatology, Universitair Ziekenhuis Brussel, Brussels, BelgiumVrije Universiteit Brussel, Liver Cell Biology research group, Laarbeeklaan 103, 1090 Brussel, Belgium; Corresponding author. Address: Vrije Universiteit Brussel, Liver Cell Biology research group, Laarbeeklaan 103, 1090 Brussel, Belgium.Vrije Universiteit Brussel, Liver Cell Biology research group, Laarbeeklaan 103, 1090 Brussel, Belgium; Corresponding author. Address: Vrije Universiteit Brussel, Liver Cell Biology research group, Laarbeeklaan 103, 1090 Brussel, Belgium.Background &amp; Aims: The progression of chronic liver disease (CLD) is characterized by excessive extracellular matrix deposition, disrupting hepatic architecture and function. Upon liver injury, hepatic stellate cells (HSCs) differentiate towards myofibroblasts and become inflammatory, proliferative and fibrogenic. To date, it is still unclear whether HSC activation is driven by similar mechanisms in different aetiologies. Methods: HSCs from multiple publicly available single-cell RNA-sequencing datasets were annotated and merged into a single-cell HSC activation atlas. Spheroid co-cultures of primary mouse hepatocytes/HSCs (n = 5) and ELISAs on patient plasma samples (n = 80) were performed to validate the mechanistic insight obtained from the HSC atlas. Results: We established an HSC activation atlas in which HSCs are clearly divided into three distinct transcriptomic profiles: quiescent HSCs, initiatory HSCs and myofibroblasts. These transcriptomic profiles are present in each of the investigated mouse liver injury models as well as in human CLDs, indicating that HSC activation is a conserved process. This activation process is driven by a core set of transcription factors independent of liver injury or species. Furthermore, we reveal novel ligands associated with activation of HSCs in multiple liver injury models and validate the profibrotic effect of parathyroid hormone. Finally, we identify COLEC10 as a conserved marker for quiescent HSCs and a biomarker of liver fibrosis in patients with different CLDs (p <0.0001). Conclusions: We reveal unexpected similarities in the regulatory mechanisms of HSCs across diverse liver injury settings and species. The HSC activation atlas has the potential to provide novel insights into liver fibrosis and steer novel treatment options. Impact and implications:: This study establishes a single-cell atlas of hepatic stellate cells across various liver injuries, highlighting a conserved activation process between different injuries and across species. The discovery of novel activating ligands and the biomarker COLEC10 in human plasma could be used to enhance diagnostic and therapeutic strategies. Additionally, the conserved activation process supports the use of any mouse model for mechanistic studies and testing of new anti-fibrotic compounds, streamlining preclinical research efforts.http://www.sciencedirect.com/science/article/pii/S2589555924002271Chronic liver diseasesingle-cell RNA-Sequencingparathyroid hormoneCOLEC10
spellingShingle Vincent Merens
Elisabeth Knetemann
Elif Gürbüz
Vincent De Smet
Nouredin Messaoudi
Hendrik Reynaert
Stefaan Verhulst
Leo A. van Grunsven
Hepatic stellate cell single cell atlas reveals a highly similar activation process across liver disease aetiologies
JHEP Reports
Chronic liver disease
single-cell RNA-Sequencing
parathyroid hormone
COLEC10
title Hepatic stellate cell single cell atlas reveals a highly similar activation process across liver disease aetiologies
title_full Hepatic stellate cell single cell atlas reveals a highly similar activation process across liver disease aetiologies
title_fullStr Hepatic stellate cell single cell atlas reveals a highly similar activation process across liver disease aetiologies
title_full_unstemmed Hepatic stellate cell single cell atlas reveals a highly similar activation process across liver disease aetiologies
title_short Hepatic stellate cell single cell atlas reveals a highly similar activation process across liver disease aetiologies
title_sort hepatic stellate cell single cell atlas reveals a highly similar activation process across liver disease aetiologies
topic Chronic liver disease
single-cell RNA-Sequencing
parathyroid hormone
COLEC10
url http://www.sciencedirect.com/science/article/pii/S2589555924002271
work_keys_str_mv AT vincentmerens hepaticstellatecellsinglecellatlasrevealsahighlysimilaractivationprocessacrossliverdiseaseaetiologies
AT elisabethknetemann hepaticstellatecellsinglecellatlasrevealsahighlysimilaractivationprocessacrossliverdiseaseaetiologies
AT elifgurbuz hepaticstellatecellsinglecellatlasrevealsahighlysimilaractivationprocessacrossliverdiseaseaetiologies
AT vincentdesmet hepaticstellatecellsinglecellatlasrevealsahighlysimilaractivationprocessacrossliverdiseaseaetiologies
AT nouredinmessaoudi hepaticstellatecellsinglecellatlasrevealsahighlysimilaractivationprocessacrossliverdiseaseaetiologies
AT hendrikreynaert hepaticstellatecellsinglecellatlasrevealsahighlysimilaractivationprocessacrossliverdiseaseaetiologies
AT stefaanverhulst hepaticstellatecellsinglecellatlasrevealsahighlysimilaractivationprocessacrossliverdiseaseaetiologies
AT leoavangrunsven hepaticstellatecellsinglecellatlasrevealsahighlysimilaractivationprocessacrossliverdiseaseaetiologies